Pharmaceutical composition for treating iatrogenic newborn calcium deposition
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A newborn, deposition disease technology, applied in the field of medicine, can solve problems such as increased heat dissipation, difficulty in constant temperature, and difficulty in receiving expected results in premature infants
Inactive Publication Date: 2016-03-23
JINAN XINSHIDAI MEDICINE SCI & TECH
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, 33% magnesium sulfate is commonly used in clinical treatment. However, using 33% magnesium sulfate for continuous moist heat compresses is difficult to maintain temperature and inconvenient to operate. It is easy to cause increased heat dissipation in newborns, especially premature infants, and it is difficult to receive the expected effect.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0032] A pharmaceutical composition for treating iatrogenic neonatal calcium salt deposition, the weight ratio of each raw material is as follows:
[0033] Pukui 6g, Chlorophytum 6g, Apricot Leaf Fangfeng 6g, Shiluo 6g, Dengtai Lian 6g, Iron Fern Chicken 6g, Water Fennel 6g, Cordyceps 6g, Iron Horsewhip 6g, Coreopsis 6g.
[0034] Preparation and use method: mix the traditional Chinese medicines of the medicine of the present invention, grind them into fine powder, and set aside. When using, take an appropriate amount of fine powder, mix thoroughly with water, tea, vinegar, egg white or glycerin and apply to the affected area.
Embodiment 2
[0036] A pharmaceutical composition for treating iatrogenic neonatal calcium salt deposition, the weight ratio of each raw material is as follows:
[0037] Pukuizi 5g, Chlorophytum 7g, Apricot Leaf Fangfeng 5g, Stone Radish 7g, Dengtai Lian 5g, Iron Fern Chicken 7g, Water Fennel 5g, Cordyceps 7g, Iron Horsewhip 5g, Coreopsis 7g.
[0038] The preparation and use methods are the same as in Example 1.
Embodiment 3
[0040] A pharmaceutical composition for treating iatrogenic neonatal calcium salt deposition, the weight ratio of each raw material is as follows:
[0041] Pukui seeds 7g, Chlorophytum 5g, Apricot Leaf Fangfeng 7g, Shiluo 5g, Dengtailian 7g, Iron Fern Chicken 5g, Water Fennel 7g, Cordyceps 5g, Iron Horsewhip 7g, Coreopsis 5g.
[0042] The preparation and use methods are the same as in Example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention belongs to the technical field of medicament, and particularly relates to a pharmaceutical composition for treating iatrogenic newborn calcium deposition. The pharmaceutical composition is prepared from the following traditional Chinese medicines in parts by weight: 4 to 6 parts of fructus livistonae, 4 to 6 parts of fewflower lysionotus herb, 4 to 6 parts of herba pimpinellae, 4 to 6 parts of pentasachme caudatum, 4 to 6 parts of arisaema bockii, 4 to 6 parts of nude pronephrium rhizome, 4 to 6 parts of all-grass of winkled marshweed, 4 to 6 parts of root of perny germander, 4 to 6 parts of lespedeza pilosa and 4 to 6 parts of coreopsis lanceolata. According to the pharmaceutical composition disclosed by the invention, all traditional Chinese medicines are in combined action, so that the common effects of clearing away heat and detoxifying, activating the blood circulation and removing swelling, regulating vital energy and eliminating stasis, and dispersing blood stasis and relieving the pain are achieved, and the pharmaceutical composition is used for treating iatrogenic newborn calcium deposition and has the advantages of high curative ratio and short treatment course.
Description
technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating iatrogenic neonatal calcium salt deposition. Background technique [0002] Iatrogenic neonatal calcium salt deposition mostly occurs in neonates and premature infants who have been infused for a long time. Because neonatal vascular development is immature, local blood vessels lose blood nourishment, and vascular permeability is high. When neonatal calcium is injected intravenously due to hypocalcemia, extravasation of the injection leads to local calcium salt deposition, or high infusion The infiltration solution is highly irritating to blood vessels, and the clinical manifestations are different degrees of induration and lumps at the injection site, and severe cases may cause local dysfunction. At present, 33% magnesium sulfate is commonly used in clinical treatment. However, continuous moist heat compress with 33% magnesiu...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more